# An In Vivo 24-Hour Recovery Study of Whole Blood by the Reveos System

> **NCT05239455** · NA · COMPLETED · sponsor: **Terumo BCT** · enrollment: 37 (actual)

## Conditions studied

- Device Validation of In-vivo Performance

## Interventions

- **DEVICE:** Reveos® Automated Blood Processing System

## Key facts

- **NCT ID:** NCT05239455
- **Lead sponsor:** Terumo BCT
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-11
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-04-30
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2025-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05239455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05239455, "An In Vivo 24-Hour Recovery Study of Whole Blood by the Reveos System". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05239455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*